chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Dyspnoea
Clinical narrative: metallic taste in mouth; breathing problems; This is a spontaneous report from contactable consumer as a patient. A 42-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) via an unspecified route of administration on 04Mar2021 at 14:00 pm in the left arm as a first dose for COVID-19 vaccination. Medical history included gastro esophageal reflux disease (GERD) and asthma. Patient was allergic to Penicillin (manufacturer unknown), Doxycycline (manufacturer unknown), trees, nuts, shellfish and environment. Concomitant medications within two weeks of vaccination included Xyzal (manufacturer unknown), Omeprazole (manufacturer unknown), Vitamin D (manufacturer unknown) and Multivitamins (manufacturer unknown). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The facility where the most recent COVID-19 vaccine was administered was at a public health clinic. On 15Mar2021 at 02:00 am (10 Days after the shot), the patient had breathing problems and metallic taste in mouth. The adverse event resulted into Emergency room/department or urgent care. The patient reported that, he was never admitted before for asthma. Therapeutic measures for the reported events were Albuterol (manufacturer unknown) and Albuterol, Steroids intravenous injections (manufacturer unknown). The clinical outcome of breathing problems and metallic taste in mouth was reported as recovering. Information about lot/batch number cannot be obtained and no further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: bodyache; headache; Nausea; This is a spontaneous report from a contactable health care professional, as a patient. A 43-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) as a first dose on an unspecified date and as a second dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) intramuscularly on 15Mar2021 at 11.30 am in the right arm for COVID-19 vaccination. Medical history and concomitant medications were not provided. Patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The facility where the most recent COVID-19 vaccine was administered was at a public health clinic. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 12:00 am, the patient developed nausea, headache and bodyache. The patient did not receive treatment for adverse events. The outcome of the events was not reported. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lip pruritus, Oral pruritus, Paraesthesia oral
Clinical narrative: Tingly/itchy face especially around thelips and tongue; Tingly/itchy face especially around the lips and tongue.; Tingly/itchy face especially around the lips and tongue.; This is a spontaneous report received from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the one dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6208) via an unspecified route of administration in Left arm on 13Mar2021 at 10:30 am (at the age of 38-year) as a single dose for COVID-19 Immunization. The patient's medical history was not reported. Allergies to medications, food, or other product reported towards Peaches (any fuzzy fruit). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021 at 09:00 am, the patient experienced Tingly/itchy face especially around the lips and tongue (Lip itching, Oral pruritus and Tingling mouth). The patient did not receive any treatment for the events. The clinical outcomes for Tingly/itchy face especially around the lips and tongue was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cheilitis, Rash, Viral test
Clinical narrative: inflamed lips and rush all over my body; inflamed lips and rush all over my body; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 12Mar2021 at 02:00PM (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included shrimps and cat's allergy. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient did not receive other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19. On an unknown date, the patient had undergone COVID-19 virus test (nasal swab) and was tested negative. On 15Mar2021 at 12:00 AM (as reported), the patient experienced inflamed lips and rush all over the body. Therapeutic measures were not taken for the events (inflamed lips and rush all over my body). The clinical outcome of the events (inflamed lips and rush all over my body) was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on right side; This is a spontaneous report received from a contactable consumer, the patient. A 75-year-old male patient received the 1st single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6206) via an unspecified route of administration in Left arm on 11Mar2021 at 11:00 am (at the age of 75 years) for COVID-19 Immunization. Concomitant medications included Cholesterol, Blood Pressure, Prostate, Vitamins. Patient's medical history was reported as Cholesterol, Blood Pressure and BPH- Benign prostatic hyperplasia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 08:00 am, the patient experienced rash on right side. The patient did not receive any treatment for the events. The clinical outcomes for rash were not recovering/not resolving. Since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Dysgeusia, Tinnitus
Clinical narrative: lightheadedness; metallic taste in mouth; chest tightness; feeling dizzy; head rush; This is a spontaneous report from a contactable healthcare professional. A 43-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), dose number 1, via unspecified route of administration and anatomical location on 15Mar2021 (at the age of 43-year-old at vaccination) as a single dose for COVID-19 vaccination. Medical history and concomitant medications for the patient were not reported. On 15Mar2021 (during 15 minutes waiting period after injection), the patient experienced light-headedness and "head rush", felt dizzy and had a metallic taste in mouth. The sensation of chest tightness was reported upon her arrival to bay. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. As therapeutic measures patient took levalbuterol (MANUFACTURER UNKNOWN) which helped her chest tightness. Other treatments included antihistamines [unknown], water and snacks. The outcome of the events was recovered on an unknown date. No follow up attempt is needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Serious pain in the left arm; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in the left arm on 26Feb2021 at 12:00 (at an unspecified age), as a single dose for COVID-19 vaccination. The patient's medical history included supraventricular tachycardia (SVT) and high cholesterol. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included Lipitor (MANUFACTURER UNKNOWN), Multi-vitamin (MANUFACTURER UNKNOWN) and Vitamin D (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 26Feb2021, the patient experienced serious pain in her left arm (8-9 out of 10) first two days. There was a gradual decline in pain level. But she still had not regained full mobility without pain 4-5 out of 10. The patient did not receive any treatment for the adverse event. The clinical outcome of serious pain in the left arm was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity, Vertigo
Clinical narrative: Nausea; fatigue; sore arm; vertigo; This is a spontaneous report received from a contactable consumer, the patient.   A 77-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) via an unknown route of administration on 09Mar2021 at 03:00 PM (at the age of 77-years) for COVID-19 immunisation. On 09Mar2021 at unknown time, the patient also received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: not provided) via an unknown route of administration for COVID-19 immunisation. Medical history includes osteoarthritis. The patient was allergic to darvon. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient experienced nausea, severe fatigue, vertigo and sore arm on 09Mar2021 at 03:00 PM, which were intense for 24 hours then intermittent for 6 days. No therapeutic measures were taken as a result of these events. On an unknown date, the patient was recovered from the events nausea, severe fatigue, vertigo and sore arm. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under left arm; This is a spontaneous report from a contactable non-Health care professional. A 49-year-old patient (gender unspecified) received BNT162B2 (BNT162B2), Lot/batch no: En6207, via an unspecified route of administration in the left arm on 14Mar2021 at 08:00 (at the age of 49-years-old) as second dose, single for COVID-19 immunization. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole + sodium bicarbonate (ZEGERID) and melatonin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's past drug history included BNT162B2 (BNT162B2), Lot/batch no: El9266), first dose, single via an unspecified route of administration in the Left arm on 20Feb2021 at 16:00 for COVID-19 immunization. On 15Mar2021 at 07:00 the patient experienced Swollen lymph nodes under left arm. The patient did not receive treatment for the event. The patient was recovering from the event at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Hyperhidrosis, Insomnia
Clinical narrative: Severe body aches; Chills; Sleeplessness; Sweats; Mental fog; Headache; Nausea; This is a spontaneous report from a contactable Non-Health care professional, the patient. A 65-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 26Feb2021 at 09:45 (at the age of 65-years-old), as a second single dose for COVID-19 vaccination and received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 05Feb2021 at 10:15 (at the age of 65-years-old), as a first single dose for COVID-19 vaccination The patient's medical history was not provided. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not provided. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 27Feb2021 at 00:00, the patient experienced headache, nausea followed by chills, sweats, severe body aches, sleeplessness, and mental fog for 72 hours. However, the headache and nausea did not abate. The patient received the treatment for the adverse events and was still under the treatment at the time of the report. The patient was testing for temporal arteri. The clinical outcome of headache, nausea, chills, sweats, severe body aches, sleeplessness and mental fog was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Severe body aches; Chills; Sleeplessness; Sweats; Mental fog; Headache; Nausea; This is a spontaneous report from a contactable Non-Health care professional, the patient. A 65-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 26Feb2021 at 09:45 (at the age of 65-years-old), as a second single dose for COVID-19 vaccination and received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 05Feb2021 at 10:15 (at the age of 65-years-old), as a first single dose for COVID-19 vaccination The patient's medical history was not provided. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not provided. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 27Feb2021 at 00:00, the patient experienced headache, nausea followed by chills, sweats, severe body aches, sleeplessness, and mental fog for 72 hours. However, the headache and nausea did not abate. The patient received the treatment for the adverse events and was still under the treatment at the time of the report. The patient was testing for temporal arteri. The clinical outcome of headache, nausea, chills, sweats, severe body aches, sleeplessness and mental fog was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Very sore arm of shot; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via unspecified route of administration in the left arm on 15Mar2021 at 03:00 (at the age of 67-years-old) as a single dose for Covid-19 immunisation. The patient's medical history and Concomitant medication were not reported. Allergies to medications, food, or other products was reported as None. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The Patient had not tested positive for COVID-19 since having the vaccine. The patient received the most recent dose of COVID-19 vaccine in a Public Health Clinic/Administration facility. On 15Mar2021, the patient experienced pain in arm. The patient did not receive treatment for the reported event. The event pain in arm was recovering at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Ear discomfort, Hyperhidrosis
Clinical narrative: Ear popping; Diaphoretic; Chills; Lightheadedness; This is a spontaneous report received from a contactable healthcare professional. This healthcare professional (reporter) reported for a 34-year-old female patient, who received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN6205) on 16Mar2021 (at the age of 34-year) via an unspecified route of administration for COVID-19 Immunization. No medical history and concomitant medications were reported by the patient. Her past medical history included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number; Unknown) on an unknown date via an unspecified route of administration for COVID-19 Immunization. On 16Mar2021, 15 minutes after vaccination, she experienced light-headedness. She denied rash, hives, shortness of breath. The patient complained of chills and ear popping and her appearance was diaphoretic. She also denied facial swelling, ear pain and runny nose. Her treatment for the events included snacks, prolonged observation and slow position changes. The follow up response to treatment was excellent. The patient was stable to go home and follow up with PCP however the clinical outcome for the reported events chills, ear popping, diaphoretic and light-headedness was unknown (as it was not specified). No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This is a spontaneous report received from a contactable other health care professional, the patient. A 40-year-old female patient received first dose of BNT162B2 (BNT162B2) (Lot/batch no: = EN6208) via an unknown route of administration on 14Mar2021 at 11:30am for COVID-19 immunisation. Medical history and past drug history were not reported for the patient. The patient received Lo Lo Estrin FE Birth Control, QD within 2 weeks of vaccination. Allergy to Vicodin was reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient's Lab Tests were not reported.  Patient experienced hives all over my low, mid and upper back as well as back of neck. The patient described the hives as raised, warm and painful to the touch similar to a severe sun burn.  The patient could not lay or apply pressure to the area. After 48 hours the hives first began to subside. No therapeutic measures included the use of a handheld massager on her back and neck, the same areas where hives developed. The clinical outcome for the event was reported as recovering/ resolving. No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Feeling abnormal, Heart rate increased, Insomnia
Clinical narrative: brain fog; tired; Cold hands and feet; rapid heart beat; body aches; shaky; anxiety; insomnia; This is a spontaneous report from contactable other healthcare professional as a patient. A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EL9267) via an unspecified route of administration on 24Feb2021 at 15:30 pm in the left arm as a first dose for COVID-19 vaccination (age at the vaccination 52-years-old). Medical history and concomitant medications were not provided. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19 (details unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 25Feb2021, the patient experienced cold hands and feet, body aches, tired, shaky, rapid heart beat, insomnia, anxiety and brain fog. The patient did not receive treatment for adverse events. The outcome of the events of cold hands and feet, body aches, tired, shaky, rapid heart beat, insomnia, anxiety and brain fog was reported as recovered. No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral coldness, Tremor
Clinical narrative: brain fog; tired; Cold hands and feet; rapid heart beat; body aches; shaky; anxiety; insomnia; This is a spontaneous report from contactable other healthcare professional as a patient. A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EL9267) via an unspecified route of administration on 24Feb2021 at 15:30 pm in the left arm as a first dose for COVID-19 vaccination (age at the vaccination 52-years-old). Medical history and concomitant medications were not provided. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19 (details unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 25Feb2021, the patient experienced cold hands and feet, body aches, tired, shaky, rapid heart beat, insomnia, anxiety and brain fog. The patient did not receive treatment for adverse events. The outcome of the events of cold hands and feet, body aches, tired, shaky, rapid heart beat, insomnia, anxiety and brain fog was reported as recovered. No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dry mouth, Dyspepsia, Fatigue, Headache
Clinical narrative: Fatigue; Indigestion; chest tightness; Headache; watery eyes; stuffy head; mild fever; flulike aches; sore arm; Very thirsty; dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch no:EN6207), via an unspecified route of administration in his left arm on 10Mar2021 at 15:00 (at the age of 55-years-old) for COVID-19 immunisation. Medical history included overweight and mild hypertension. The patient had no allergies to medications, food or other products. The patient's concomitant medications included lutein, zinc, vitamin C, vitamin D3, tylenol and ibuprofen. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021, the patient experienced sore arm and on the same day she was very thirsty and dry mouth for first 12 hours. On 12Mar2021, the patient experienced headache midday about 36 hours after shot and got progressively worsen until about 72 hours and concurrently she experienced flulike aches, mild fever, stuffy head and watery eyes. On 13Mar2021, the patient had some chest tightness and indigestion. On 14Mar2021, the patient felt fatigue. Therapeutic measures were not taken for events experienced. The clinical outcome of the event headache was resolved. The clinical outcome of other events was resolving. No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lacrimation increased, Pain in extremity, Pyrexia, Thirst
Clinical narrative: Fatigue; Indigestion; chest tightness; Headache; watery eyes; stuffy head; mild fever; flulike aches; sore arm; Very thirsty; dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch no:EN6207), via an unspecified route of administration in his left arm on 10Mar2021 at 15:00 (at the age of 55-years-old) for COVID-19 immunisation. Medical history included overweight and mild hypertension. The patient had no allergies to medications, food or other products. The patient's concomitant medications included lutein, zinc, vitamin C, vitamin D3, tylenol and ibuprofen. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021, the patient experienced sore arm and on the same day she was very thirsty and dry mouth for first 12 hours. On 12Mar2021, the patient experienced headache midday about 36 hours after shot and got progressively worsen until about 72 hours and concurrently she experienced flulike aches, mild fever, stuffy head and watery eyes. On 13Mar2021, the patient had some chest tightness and indigestion. On 14Mar2021, the patient felt fatigue. Therapeutic measures were not taken for events experienced. The clinical outcome of the event headache was resolved. The clinical outcome of other events was resolving. No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Fatigue; Indigestion; chest tightness; Headache; watery eyes; stuffy head; mild fever; flulike aches; sore arm; Very thirsty; dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch no:EN6207), via an unspecified route of administration in his left arm on 10Mar2021 at 15:00 (at the age of 55-years-old) for COVID-19 immunisation. Medical history included overweight and mild hypertension. The patient had no allergies to medications, food or other products. The patient's concomitant medications included lutein, zinc, vitamin C, vitamin D3, tylenol and ibuprofen. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021, the patient experienced sore arm and on the same day she was very thirsty and dry mouth for first 12 hours. On 12Mar2021, the patient experienced headache midday about 36 hours after shot and got progressively worsen until about 72 hours and concurrently she experienced flulike aches, mild fever, stuffy head and watery eyes. On 13Mar2021, the patient had some chest tightness and indigestion. On 14Mar2021, the patient felt fatigue. Therapeutic measures were not taken for events experienced. The clinical outcome of the event headache was resolved. The clinical outcome of other events was resolving. No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever for about 4 hours; Aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 74-years-old non-pregnant elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318), dose number 2, via an unspecified route of administration in the left arm on 02Feb2021 at 09:45 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Past drug of the patient included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), dose number 1, via an unspecified route of administration in the left arm on 12Jan2021 at 12:30 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. The patient had no allergies to medication, food or other products. Concomitant medications of the patient included simvastatin (MANUFACTURER UNKNOWN) and Citrical (calcium) (MANUFACTURER UNKNOWN); all for unknown indication since unknown date and is unknown if ongoing. The patient had not received any other vaccines within 4 weeks prior to vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 02Feb2021 at 23:00, the patient experienced aches, chills and fever for about 4 hours. Some achiness lasted for about a total of 12 hours. No therapeutic medications were taken for the events. The clinical outcome of the events aches, chills and fever was recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Night sweats, Rash
Clinical narrative: rash under both breast the followingafternoon; Sweating and chills overnight; Sweating and chills overnight; This is a spontaneous report received from a contactable non-Health care professional. A 36-year-old non-pregnant female patient received BNT162B2 (BNT162B2), Lot Number: unknown, solution for injection, first dose, single on 15Mar2021 at 14:45, via unspecified route of administration in the left arm for Covid 19 immunisation. Medical history included mitral valve prolapse (MVP), irregular heartbeat, intravenous pyelogram (IVP) dye allergy. Concomitant medications included Zinc, vitamin D, and vitamin C for hair, skin and nails. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021 at 23:00, she experienced sweating and chills overnight and on 16Mar2021 (following afternoon), she experienced rash under both breasts. The patient did not receive treatment for the events. The patient was recovering from sweating and chills overnight. The outcome of the event rash under both breasts was not reported. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Nausea
Clinical narrative: This is a spontaneous report from a contactable Consumer, The patient.   A 37-year-old female patient received BNT162B2 (Pfizer BIONTECH- COVID-19 m-RNA vaccine): (Lot number En5318) via an unspecified route of administration in the right arm on 28Feb2021 at 08:30 (Age at the time of vaccination was 37 -years) at an unknown dose for covid -19 immunisation.  Medical history included Multiple sclerosis, high blood pressure, Penicillin, shrimp and cat dander.  The patient concomitant medications were not reported. Prior to the vaccination patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for covid-19 test. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Feb2021 at 12:00, the patient experienced High blood pressure and Nausea. The adverse events resulted in Emergency room/department or urgent care. The most recent COVID-19 vaccine was administered to the patient in a health facility. Therapeutic measures were not taken for the events. The events High blood pressure and Nausea were resolving at the time of this report. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pain; This is spontaneous case report received from a contactable consumer, the patient. A 45-year-old adult non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot/batch number: EL3247) via an unspecified route of administration on 16Mar2021 at 11:30 on left arm for COVID-19 Immunisation. Medical history included seasonal allergy and asthma. The patient did not had any allergies to medications, food or other products. The patient's concomitant medication included Zyrtec (cetrizine) for unknow indication. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot/batch number EL3247) via an unspecified route of administration on 22Feb2021 at 10:45 on left arm for COVID-19 immunisation. On 16Mar2021 at 14:00, she experienced injection (vaccination) site pain. Therapeutic measures were taken for event experienced and included acetaminophen. The clinical outcome of the event injection site pain was recovered.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Severe vertigo; This is a Spontaneous report from a contactable patient. A 30-years-old adult non-pregnant female patient received a dose of BNT162B2 via an unspecified route of administration for COVID-19 immunisation. Medical history included anxiety and ADHD (attention-deficit/hyperactivity disorder) and some nuts allergy. Concomitant medications included bupropion (WELLBUTRIN) and atomoxetine (STRATETTRA); both have been administered for unknown indication (within 2 weeks of vaccination). It was further reported that prior to vaccination, it was unknown if she was diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19. Moreover, she did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 07:00AM, she experienced severe vertigo while driving however no fever. No therapeutic measures were taken for this event. At the time of the report, the outcome of the event was recovering. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: right arm started hurting, patient can hardly raise arm without a shooting pain at shot sight; There is also some swelling; This is a spontaneous report received from a contactable consumer, the patient.   A 73-years-old non-pregnant female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6198) via an unspecified route on 03Mar2021 at 08:45 AM (at the age of 73-years) as a single dose in right arm for COVID-19 vaccination. The patient's past drug history included 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EM9810) via an unspecified route on 02Feb2021 at 07:45 AM as a single dose in left arm for COVID-19 vaccination. Medical history included diabetes, high blood pressure and obesity. The patient was allergic to dye injected for tests, shrimp, penicillin, amphetamine and barbiturates. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The facility where the most recent COVID-19 vaccine was administered was at a hospital. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included insulin, glimepiride, simvastatin, lasix and vitamin d3. The patient received these medications within 2 weeks of vaccination and exact therapy dates and indication for these medications were not reported. On 10Mar2021 at 04:00 PM (a week after the shot), the patient's right arm started hurting which was coming and going. Sometimes the patient could hardly raise her arm without a shooting pain at shot sight. There was also some swelling. The patient did not receive any treatment for these events. At the time of this report, the patient was not recovered from the events vaccination site pain and vaccination site swelling. No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Fatigue; Soreness in Injection Site; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 14Mar2021 at 17:45 (at the age of 58-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history and concomitant medications was not reported. The patient had a history of allergy to Penicillin and Sulfa. Prior to the vaccination, the patient was not diagnosed with Covid-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced fatigue for next 2 days and had soreness in injection site. The patient did not receive any treatment for the adverse events. The clinical outcomes of fatigue and soreness in injection site was recovering.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Loose stools for 5 days following the vaccine; This is a spontaneous report from non-contactable consumer as a patient. A 41-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) via an unspecified route of administration on 03Mar2021 at 12.30 pm in the left arm as a first dose for COVID-19 vaccination (at the age of 41-years-old). Medical history included moderate asthma and thyroid nodules. Concomitant medication was not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The facility where the most recent COVID-19 vaccine was administered was at a pharmacy. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021 at 09:15 am (following the vaccine), the patient experienced loose stools for 5 days. No therapeutic measures were taken as a result of the event. The outcome of the event was recovered on an unknown date. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Lymphadenopathy, Nausea, Vaccination site pain
Clinical narrative: Nausea; Soreness at the injection site; Dizziness; Headache; Lymphadenopathy under the arm andon neck near collar bone (on the rightside); This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EL3247), via an unspecified route of administration in the right arm on 15Mar2021 02:00 PM (at the age of 51-years-old) as a single dose for COVID-19 vaccination. Medical history included penicillin allergy. The patient did not have any allergies to food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient past drug history included BNT162B2 (BNT162B2 Lot/batch no: EL3247), dose number 1 via an unspecified route of administration in the right arm on 22Feb2021 at 02:00 PM as single dose for COVID-19 immunization. On 16Mar2021 at 02:00 AM, the patient experienced Headache, Nausea, Dizziness, Soreness at the injection site, Lymphadenopathy under the arm and on neck near collar bone (on the right side). No therapeutic measures were taken for the event. The clinical outcome of the event Headache, Nausea, Dizziness, Soreness at the injection site, Lymphadenopathy was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pyrexia
Clinical narrative: Fever 100.7; Dizziness; Headache; This is a spontaneous report from a contactable non-healthcare professional as a parent. A 22-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) as a first dose on 22Feb2021 at 14:00 pm in the left arm and as a second dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) on 14Mar2021 at 10:00 am in the left arm for COVID-19 vaccination. Medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 10:00 am, the patient had fever 100.7, dizziness and headache started about 24 hours after vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive treatment for adverse events. The outcome of the events was reported as recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Maternal exposure during pregnancy, Nausea, Vaccination site pain
Clinical narrative: Maternal exposure during pregnancy, second trimester; Soreness at injection site; Headache; Nausea; Tiredness; Vomiting (unable to keep food or liquids down); This is a spontaneous report received from a contactable consumer, the patient. A 28-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 vaccination. The patient's last menstrual period (LMP) was reported as 26Oct2020 and the patient gestation period at time of vaccination was reported as 20 weeks. The patient pregnancy due date was 02Aug2021. Medical history included COVID-19 which was diagnosed prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), prenatal vitamins (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), and diphenhydramine hydrochloride (BENADRYL); all for unknown indications from an unknown date (within 2 weeks of vaccination) and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced soreness at injection site, tiredness, nausea, vomiting (unable to keep food or liquids down), and headache. No therapeutic measures were taken for the events. The clinical outcomes of the vaccination site pain, tiredness, nausea, vomiting, and headache were not recovered at the time of this report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Maternal exposure during pregnancy, second trimester; Soreness at injection site; Headache; Nausea; Tiredness; Vomiting (unable to keep food or liquids down); This is a spontaneous report received from a contactable consumer, the patient. A 28-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 vaccination. The patient's last menstrual period (LMP) was reported as 26Oct2020 and the patient gestation period at time of vaccination was reported as 20 weeks. The patient pregnancy due date was 02Aug2021. Medical history included COVID-19 which was diagnosed prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), prenatal vitamins (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), and diphenhydramine hydrochloride (BENADRYL); all for unknown indications from an unknown date (within 2 weeks of vaccination) and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced soreness at injection site, tiredness, nausea, vomiting (unable to keep food or liquids down), and headache. No therapeutic measures were taken for the events. The clinical outcomes of the vaccination site pain, tiredness, nausea, vomiting, and headache were not recovered at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This is a spontaneous report from a contactable other health care professional. A non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch no: Unknown) via unspecified route of administration as a single dose for COVID-19 Immunisation on an unspecified date. Medical history and concomitant drugs were not reported. It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if patient tested positive for COVID-19 since having the vaccine. On an unspecified date, the patient experienced fever. No therapeutic measures were taken as a result of these events. The clinical outcome of the event was recovered. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Had a hard, flat, painful swelling about the size of a nickle.; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old, non-pregnant female patient received second dose of BNT162B2[PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6198], via Left arm and an unspecified route of administration2nd dose on 02Mar2021 at 04.15 pm (at the age of 74-years-old) as a single dose for Covid 19 immunisation. Medical history included Heart stent, overweight, and arthritis. The patient had a history of Lisinopril allergy. Patient previously received BNT162B2[PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN5318] 1st dose on 09Feb2021 at 04.15 pm as a single dose for Covid 19 immunisation. Concomitant medications included Atorvastatin (Manufacturer unknown) and aspirin (Manufacturer unknown) for an unspecified indication. On 02Mar2021 06:00 PM, the patient experienced hard, flat, painful swelling about the size of a nickle. It lasted about 5 days. The patient had recovered from the event of painful swelling at the time of reporting. No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: exhaustion; chills; Fever 101; This is a spontaneous report from a non-contactable consumer. An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/lot no unknown) through an unspecified route of administration on 15Mar2021 for COVID 19 immunization. No relevant Past medical and concomitant history provided at time of reporting event. Patient was not tested positive for covid19 since vaccination and not diagnosed for it prior to vaccination. On 15Mar2021, the patient started experiencing Fever 101, chills, exhaustion. No therapeutic measures were taken for the adverse event. The patient not recovered from the events at the time of reporting. Information about lot/batch no cannot be obtained. No further information is expected